These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
607 related articles for article (PubMed ID: 28222627)
1. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial. Gordo AC; Walker C; Armada B; Zhou D J Int Med Res; 2017 Feb; 45(1):59-74. PubMed ID: 28222627 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nonsteroidal anti-inflammatory drugs in Asian patients with knee osteoarthritis: summary of a randomized, placebo-controlled study. Essex MN; O'Connell MA; Behar R; Bao W Int J Rheum Dis; 2016 Mar; 19(3):262-70. PubMed ID: 25990559 [TBL] [Abstract][Full Text] [Related]
3. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib. Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454 [TBL] [Abstract][Full Text] [Related]
4. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]. Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112 [TBL] [Abstract][Full Text] [Related]
5. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib. Fleischmann R; Sheldon E; Maldonado-Cocco J; Dutta D; Yu S; Sloan VS Clin Rheumatol; 2006 Feb; 25(1):42-53. PubMed ID: 16132165 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Luyten FP; Geusens P; Malaise M; De Clerck L; Westhovens R; Raeman F; Vander Mijnsbrugge D; Mathy L; Hauzeur JP; De Keyser F; Van den Bosch F Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies. Bingham CO; Sebba AI; Rubin BR; Ruoff GE; Kremer J; Bird S; Smugar SS; Fitzgerald BJ; O'Brien K; Tershakovec AM Rheumatology (Oxford); 2007 Mar; 46(3):496-507. PubMed ID: 16936327 [TBL] [Abstract][Full Text] [Related]
8. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial. DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961 [TBL] [Abstract][Full Text] [Related]
9. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Conaghan PG; Dickson J; Bolten W; Cevc G; Rother M Rheumatology (Oxford); 2013 Jul; 52(7):1303-12. PubMed ID: 23542612 [TBL] [Abstract][Full Text] [Related]
10. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Hochberg MC; Martel-Pelletier J; Monfort J; Möller I; Castillo JR; Arden N; Berenbaum F; Blanco FJ; Conaghan PG; Doménech G; Henrotin Y; Pap T; Richette P; Sawitzke A; du Souich P; Pelletier JP; Ann Rheum Dis; 2016 Jan; 75(1):37-44. PubMed ID: 25589511 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Rother M; Lavins BJ; Kneer W; Lehnhardt K; Seidel EJ; Mazgareanu S Ann Rheum Dis; 2007 Sep; 66(9):1178-83. PubMed ID: 17363401 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607 [TBL] [Abstract][Full Text] [Related]
13. Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a 13 week, randomised, double blind study versus placebo and celecoxib. Tannenbaum H; Berenbaum F; Reginster JY; Zacher J; Robinson J; Poor G; Bliddal H; Uebelhart D; Adami S; Navarro F; Lee A; Moore A; Gimona A Ann Rheum Dis; 2004 Nov; 63(11):1419-26. PubMed ID: 15020310 [TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint. Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies. Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP; J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774 [TBL] [Abstract][Full Text] [Related]
16. A Randomized, Multicenter, Phase III Trial to Evaluate the Efficacy and Safety of Polmacoxib Compared with Celecoxib and Placebo for Patients with Osteoarthritis. Lee M; Yoo J; Kim JG; Kyung HS; Bin SI; Kang SB; Choi CH; Moon YW; Kim YM; Han SB; In Y; Choi CH; Kim J; Lee BK; Cho S Clin Orthop Surg; 2017 Dec; 9(4):439-457. PubMed ID: 29201297 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595 [TBL] [Abstract][Full Text] [Related]
18. A double blind, randomized, placebo controlled study to evaluate the efficacy of erythromycin in patients with knee effusion due to osteoarthritis. Sadreddini S; Noshad H; Molaeefard M; Moloudi R; Ardalan MR; Ghojazadeh M Int J Rheum Dis; 2009 Apr; 12(1):44-51. PubMed ID: 20374316 [TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial evaluating transdermal Ibuprofen for moderate to severe knee osteoarthritis. Varadi G; Zhu Z; Blattler T; Hosle M; Loher A; Pokorny R; Frey D; Carter SG Pain Physician; 2013; 16(6):E749-62. PubMed ID: 24284856 [TBL] [Abstract][Full Text] [Related]
20. Assessment of pain and activity using an electronic pain diary and actigraphy device in a randomized, placebo-controlled crossover trial of celecoxib in osteoarthritis of the knee. Trudeau J; Van Inwegen R; Eaton T; Bhat G; Paillard F; Ng D; Tan K; Katz NP Pain Pract; 2015 Mar; 15(3):247-55. PubMed ID: 24494935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]